| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/27/2006 | EP1608317A4 Dipeptidyl peptidase inhibitors |
| 12/27/2006 | EP1597260B1 Triazole compounds useful in therapy |
| 12/27/2006 | EP1592699B1 Avermectin and avermectin monosaccharide derivatives substituted in the 4''- or 4'-position having pesticidal properties |
| 12/27/2006 | EP1585748B1 PYRAZOLO 3,4-d PYRIMIDINE DERIVATIVES AND THEIR USE I N THE TREATMENT OF H.PYLORI INFECTION |
| 12/27/2006 | EP1558255B1 Dual binding site acetylcholinesterase inhibitors for the treatment of alzheimer's disease |
| 12/27/2006 | EP1554303B1 Polymorph b of a known thiophenecarboxylic acid dodecahydrocyclopenta[a]phenanthrenyl ester |
| 12/27/2006 | EP1554259B1 Novel bicyclic inhibitors of hormone sensitive lipase |
| 12/27/2006 | EP1534717B1 Beta-lactamase inhibitor prodrug |
| 12/27/2006 | EP1534682B1 Novel molecules derived from noraporphine |
| 12/27/2006 | EP1534282B1 Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases |
| 12/27/2006 | EP1513861B1 New etonogestrel esters |
| 12/27/2006 | EP1507873A4 Parallel stranded duplexes of deoxyribonucleic acid and methods of use |
| 12/27/2006 | EP1483264B1 1-allyl ergot alkaloid derivatives, method for producing the same and the use thereof for preventing and treating migraine |
| 12/27/2006 | EP1480961B1 Glutaminyl based dpiv inhibitors |
| 12/27/2006 | EP1448559B1 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-dione benzenesulfonate; process for its preparation; polymorphs i, ii and iii thereof; and its use as pharmaceutical active ingredient |
| 12/27/2006 | EP1443925B1 Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors |
| 12/27/2006 | EP1436267B1 Lactam derivatives as antagonists for human 11cby receptors |
| 12/27/2006 | EP1430051B1 N-(4-(4-methylthiazol-5-yl)pyrimidin-2-yl)-n-phenylamines as antiproliferative compounds |
| 12/27/2006 | EP1429843B1 Combination of a pde inhibitor and a leukotriene receptor antagonist |
| 12/27/2006 | EP1427423B1 Benzothiazepine and benzothiadiazepine derivatives with ileal bile acid transport (ibat) inhibitory activity for the treatment hyperlipidaemia |
| 12/27/2006 | EP1417180B1 Preparation of aminopyrimidine compounds |
| 12/27/2006 | EP1406876B1 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors |
| 12/27/2006 | EP1404704B1 Bridged bicyclic serine protease inhibitors |
| 12/27/2006 | EP1392276B1 Potentiation of therapeutic effects of polyunsaturated fatty acids |
| 12/27/2006 | EP1390344B1 Benzamidoacetonitrile derivatives and their use as antiparasitics |
| 12/27/2006 | EP1381604B1 Amyloid plaque aggregation inhibitors and diagnostic imaging agents |
| 12/27/2006 | EP1379515B1 Lipid lowering biphenylcarboxamides |
| 12/27/2006 | EP1373500B1 Gene involved in v(d)j recombination and/or dna repair |
| 12/27/2006 | EP1368317B1 Tryptase inhibitors |
| 12/27/2006 | EP1353928B1 Process for preparing clopidogrel |
| 12/27/2006 | EP1345895B1 Novel 1,2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and the use thereof for treating disorders of the lipid metabolism |
| 12/27/2006 | EP1332372B1 Net, a transcription factor of the tcf family, as regulator of angiogenic factor expression |
| 12/27/2006 | EP1313695B1 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| 12/27/2006 | EP1299374B1 Novel non-psychotropic cannabinoids |
| 12/27/2006 | EP1297147B1 Compositions for the diagnosis and treatment of herpes simplex virus infection |
| 12/27/2006 | EP1284717B1 Formulation based on heparin, glycosaminoglycan or heparinoid, use of the formulation and the formulation base |
| 12/27/2006 | EP1242401B1 Cytotoxic agents comprising taxanes and their therapeutic use |
| 12/27/2006 | EP1231898B1 Apparatus and method for preparing microparticles |
| 12/27/2006 | EP1226144B1 Alkylamino substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase |
| 12/27/2006 | EP1222924B1 Anticancer agents |
| 12/27/2006 | EP1187826B1 Heterocyclic derivatives useful as anticancer agents |
| 12/27/2006 | EP1173255B1 Use of pirenoxine for the protection of corneal tissues in photokeratectomy |
| 12/27/2006 | EP1103560B1 Novel thiazolidine derivatives |
| 12/27/2006 | EP1084252B1 Nucleic acid vaccines for prevention of flavivirus infection |
| 12/27/2006 | EP1083885B1 Delavirdine tablet formulation |
| 12/27/2006 | EP1034273B1 Histamine and serotonin binding molecules |
| 12/27/2006 | EP1021410B1 Prostaglandin agonists and their use to treat bone disorders |
| 12/27/2006 | EP0998495B1 Amyloid beta protein (globular assembly and uses thereof) |
| 12/27/2006 | EP0980246B1 Therapy for constipation |
| 12/27/2006 | EP0918458B1 Antimicrobial treatment for herpes simplex virus and other infectious diseases |
| 12/27/2006 | EP0888290B1 Azulenyl nitrone spin trapping agents, methods of making and using same |
| 12/27/2006 | EP0844875B1 Use of basic l-carnitine and acyl derivatives for lowering ceramide levels |
| 12/27/2006 | CN1886506A Protein expressed in nk cell |
| 12/27/2006 | CN1886421A Hemiasterlin derivatives and uses thereof |
| 12/27/2006 | CN1886419A Crystalline forms of 3-beta-amino 17-methylene androstane-6-alpha 7-beta-diol hydrochloride |
| 12/27/2006 | CN1886418A 雌激素受体调节剂 Estrogen receptor modulators |
| 12/27/2006 | CN1886416A Comt抑制剂 Comt inhibitors |
| 12/27/2006 | CN1886408A Polymorphous forms of rifaximin, processes for production and use in medicinal preparations |
| 12/27/2006 | CN1886407A Bicyclic pyrazolyl and imidazolyl compounds and uses thereof |
| 12/27/2006 | CN1886405A Pyrrolo-pyrazine derivatives useful as CB1-modulators |
| 12/27/2006 | CN1886404A 6-(2,4,6-trifluorophenyl)-triazolopyrimidines, method for the production thereof, use thereof for controlling harmful fungi, and substances containing the same |
| 12/27/2006 | CN1886403A Use of a compound of formula (i) as an inhibitor of aromatase for therapeutic purposes and compounds of formula (1) thereas |
| 12/27/2006 | CN1886402A pyrimidin-2-amine derivates and their use as a2b adenosine receptor antagonists |
| 12/27/2006 | CN1886401A Benzoyl amino pyridil carboxylic acid derivatives as gluokinase activators |
| 12/27/2006 | CN1886400A 9, 10-alpha, alpha-OH-taxane analogs and methods for production thereof |
| 12/27/2006 | CN1886399A 喹唑啉衍生物 Quinazoline derivatives |
| 12/27/2006 | CN1886397A 3-heterocyclyl-indole derivatives as inhibitors of glycogen synthase kinase-3 (gsk-3) |
| 12/27/2006 | CN1886396A Process for producing 2-acylthiophene compound |
| 12/27/2006 | CN1886393A Modulators of ATP-binding cassette transporters containing cycloalkyl or pyranyl groups |
| 12/27/2006 | CN1886392A Novel benzofuran derivatives, which can be used in prophylaxis or treatment of 5-ht6 receptor-related disorder |
| 12/27/2006 | CN1886389A 喹喔啉化合物 Quinoxaline compounds |
| 12/27/2006 | CN1886388A Developments in biologically active methylene blue derivatives(2) |
| 12/27/2006 | CN1886386A Phenylene derivative having tetrazole ring or thiazolidinedione ring |
| 12/27/2006 | CN1886385A Crystals of phenylalanine derivatives and production methods thereof |
| 12/27/2006 | CN1886384A Quinazolinone compounds as anticancer agents |
| 12/27/2006 | CN1886383A Process for the preparation of amorphous rosuvastatin calcium |
| 12/27/2006 | CN1886380A Benzoimidazole compounds |
| 12/27/2006 | CN1886379A Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| 12/27/2006 | CN1886378A 1,4-disubstituted isoquinilone derivatives as RAF-kinase inhibitors useful for the treatment of proliferative diseases |
| 12/27/2006 | CN1886377A Benzoyl amino pyridyl carboxylic acid derivatives useful as glucokinase (GLK) activators |
| 12/27/2006 | CN1886375A Piperidine compound and method for producing same |
| 12/27/2006 | CN1886372A 1-alkyl-3-thio-substituted indole-2-alkynoic acids useful for the treatment for alzheimer's disease and related conditions |
| 12/27/2006 | CN1886370A N-acyl-n -benzyl-alkylendiamino derivatives |
| 12/27/2006 | CN1886367A Fused ring dicationic anti-protozoan agents and their prodrugs |
| 12/27/2006 | CN1886366A Cyclopentyl derivates |
| 12/27/2006 | CN1886365A Novel salicylic anilides |
| 12/27/2006 | CN1886364A Selective peroxisome proliferator activated receptor modulators |
| 12/27/2006 | CN1886363A Amino acids with affinity for the alpha2delta-protein |
| 12/27/2006 | CN1886353A Methods of [11C]-radiolabelling phenothiazine and phenothiazine-like compounds |
| 12/27/2006 | CN1886157A Pharmaceutical combinations |
| 12/27/2006 | CN1886152A Minimization of drug oxidation in drug irradiated excipients formulations |
| 12/27/2006 | CN1886147A Compositions for the treatment of affections of the oral cavity and upper respiratory tract |
| 12/27/2006 | CN1886146A Compositions for the treatment of atopic dermatitis, skin allergic conditions and acne |
| 12/27/2006 | CN1886143A Agent and method for treating cancer comprising strontium, amino acid(s) and mineral agent(s) |
| 12/27/2006 | CN1886142A Methods and means for modulating lipid metabolism |
| 12/27/2006 | CN1886141A T-type calcium channel inhibitor |
| 12/27/2006 | CN1886140A Methods for treating bladder dysfunction |
| 12/27/2006 | CN1886139A Soft steroid compositions for use in dry powder inhalers |
| 12/27/2006 | CN1886138A CDK2 antagonists as short form C-MAF transcription factor antagonists for treatment of glaucoma |
| 12/27/2006 | CN1886137A Oral formulations of desoxypeganine and uses thereof. |